Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-001307
Filing Date
2025-01-10
Accepted
2025-01-10 18:00:14
Documents
2
Period of Report
2025-01-09

Document Format Files

Seq Description Document Type Size
1 form3-01102025_110110.html 3  
1 form3-01102025_110110.xml 3 1720
2 ex24-01102025_110122.htm EX-24 8286
  Complete submission text file 0001415889-25-001307.txt   11470
Mailing Address NITROMED, INC. 125 SPRING STREET LEXINGTON MA 02421
Business Address
JONES WILLIAM A JR (Reporting) CIK: 0001373097 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39402 | Film No.: 25524191

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)